Literature DB >> 27298303

Pulmonary Veno-occlusive Disease and Pulmonary Hypertension in Dogs: Striking Similarities to the Human Condition.

K R Stenmark1, G M Krafsur2, R M Tuder3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27298303      PMCID： PMC5802371          DOI： 10.1177/0300985816647454

Source DB:  PubMed          Journal:  Vet Pathol        ISSN： 0300-9858            Impact factor:   2.221


× No keyword cloud information.
  18 in total

Review 1.  Pulmonary veno-occlusive disease: recent progress and current challenges.

Authors:  David Montani; Dermot S O'Callaghan; Laurent Savale; Xavier Jaïs; Azzedine Yaïci; Sophie Maitre; Peter Dorfmuller; Olivier Sitbon; Gérald Simonneau; Marc Humbert
Journal:  Respir Med       Date:  2010-04-24       Impact factor: 3.415

2.  Modern age pathology of pulmonary arterial hypertension.

Authors:  Elvira Stacher; Brian B Graham; James M Hunt; Aneta Gandjeva; Steve D Groshong; Vallerie V McLaughlin; Marsha Jessup; William E Grizzle; Michaela A Aldred; Carlyne D Cool; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2012-06-07       Impact factor: 21.405

Review 3.  Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

Authors:  Benoît Ranchoux; Sven Günther; Rozenn Quarck; Marie-Camille Chaumais; Peter Dorfmüller; Fabrice Antigny; Sébastien J Dumas; Nicolas Raymond; Edmund Lau; Laurent Savale; Xavier Jaïs; Olivier Sitbon; Gérald Simonneau; Kurt Stenmark; Sylvia Cohen-Kaminsky; Marc Humbert; David Montani; Frédéric Perros
Journal:  Am J Pathol       Date:  2014-12-11       Impact factor: 4.307

Review 4.  A critical appraisal of the updated 2014 Nice Pulmonary Hypertension Classification System.

Authors:  Edmund M T Lau; Marc Humbert
Journal:  Can J Cardiol       Date:  2015-01-16       Impact factor: 5.223

5.  Pulmonary Veno-Occlusive Disease: A Newly Recognized Cause of Severe Pulmonary Hypertension in Dogs.

Authors:  K Williams; K Andrie; A Cartoceti; S French; D Goldsmith; S Jennings; S L Priestnall; D Wilson; A Jutkowitz
Journal:  Vet Pathol       Date:  2016-02-29       Impact factor: 2.221

6.  Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis.

Authors:  Gretchen A LaRusch; Fakhri Mahdi; Zia Shariat-Madar; Gregory Adams; Robert G Sitrin; Wan Ming Zhang; Keith R McCrae; Alvin H Schmaier
Journal:  Blood       Date:  2010-03-12       Impact factor: 22.113

7.  Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.

Authors:  David Montani; Lara Achouh; Peter Dorfmüller; Jérôme Le Pavec; Benjamin Sztrymf; Colas Tchérakian; Anne Rabiller; Rehan Haque; Olivier Sitbon; Xavier Jaïs; Philippe Dartevelle; Sophie Maître; Frédérique Capron; Dominique Musset; Gérald Simonneau; Marc Humbert
Journal:  Medicine (Baltimore)       Date:  2008-07       Impact factor: 1.889

8.  Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.

Authors:  James M Hunt; Brian Bethea; Xiang Liu; Aneta Gandjeva; Pradeep P A Mammen; Elvira Stacher; Marina R Gandjeva; Elisabeth Parish; Mario Perez; Lynelle Smith; Brian B Graham; Wolfgang M Kuebler; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-13       Impact factor: 5.464

9.  Origin, differentiation, and maturation of human pulmonary veins.

Authors:  Susan M Hall; Alison A Hislop; Sheila G Haworth
Journal:  Am J Respir Cell Mol Biol       Date:  2002-03       Impact factor: 6.914

Review 10.  Relevant issues in the pathology and pathobiology of pulmonary hypertension.

Authors:  Rubin M Tuder; Stephen L Archer; Peter Dorfmüller; Serpil C Erzurum; Christophe Guignabert; Evangelos Michelakis; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Nicholas W Morrell
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.